Tanta Protocol for Management of COVID-19: Perspectives from a Developing Country.
Endocr Metab Immune Disord Drug Targets
; 21(10): 1775-1780, 2021.
Article
in English
| MEDLINE | ID: covidwho-1562450
ABSTRACT
In late 2019, SARS-COV-2 disease was firstly discovered in Wuhan, China and then it infected millions of people worldwide. Later, the World Health Organization (WHO) described COVID-19 as the first pandemic invading the world in the 21st century. The WHO has declared that the emerging infection will last long enough to force adjustments not only in people's lifestyles but also in the health care system. This amendment is expected to spread through many medical practices and specialties. A lot of diagnostic and therapeutic modalities have been proposed for COVID-19 management. The best strategy for the management of patients requires a multi-disciplinary team approach with correct decisions regarding the right timing of each modality of treatment. The participating multidisciplinary team for COVID-19 management includes six infectious diseases experts in Tanta University; one critical care management expert, an emergency medicine expert and two pharmacists in Tanta University. In this review, we reported our multi-disciplinary team experience with up to date literature guidance to propose a valid protocol for the management of COVID-19 patients in a limited resources setting.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Patient Care Team
/
Disease Management
/
Developing Countries
/
Academic Medical Centers
/
COVID-19
/
Health Resources
Type of study:
Observational study
Limits:
Humans
Country/Region as subject:
Africa
Language:
English
Journal:
Endocr Metab Immune Disord Drug Targets
Journal subject:
Allergy and Immunology
/
Endocrinology
/
Metabolism
/
Drug Therapy
Year:
2021
Document Type:
Article
Affiliation country:
1871530320999201117142305
Similar
MEDLINE
...
LILACS
LIS